A retrospective study assessing risk factors for hepatotoxicity after use of sotorasib in KRAS mutated NSCLC
Latest Information Update: 14 Sep 2022
At a glance
- Drugs Sotorasib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
Most Recent Events
- 14 Sep 2022 New trial record
- 09 Aug 2022 Results presented at the 2022 World Conference on Lung Cancer